loader
Please Wait
Applying Filters...

Renejix CDMO Partner for Small Molecule Oral Dosage Forms Renejix CDMO Partner for Small Molecule Oral Dosage Forms

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    Technical details about UNII-16K08R7NG0, learn more about the structure, uses, toxicity, action, side effects and more

    Client Email Product
    Menu

    UNII-16K08R7NG0

    APIs // Active Pharmaceutical Ingredients

    PharmaCompass

    Biophore is a research-driven global pharmaceutical company focused on niche APIs for the generic industry.

    Athena Pharmaceutiques is a Partner of Choice for Drug Delivery & Life Cycle Management.

    2D Structure
    1. Also known as: Clarithromycin citrate (1:1), 16k08r7ng0, Erythromycin, 6-o-methyl-, 2-hydroxy-1,2,3-propanetricarboxylate (salt) (1:1), 848130-51-8, Unii-16k08r7ng0, Schembl6275870
    Molecular Formula
    C44H77NO20
    Molecular Weight
    940.1  g/mol
    InChI Key
    MDRWXDRMSKEMRE-AZFLODHXSA-N
    FDA UNII
    16K08R7NG0
    1 2D Structure

    2D Structure

    2 Identification
    2.1 Computed Descriptors
    2.1.1 IUPAC Name
    (3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-6-[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-14-ethyl-12,13-dihydroxy-4-[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyloxan-2-yl]oxy-7-methoxy-3,5,7,9,11,13-hexamethyl-oxacyclotetradecane-2,10-dione;2-hydroxypropane-1,2,3-tricarboxylic acid
    2.1.2 InChI
    InChI=1S/C38H69NO13.C6H8O7/c1-15-26-38(10,45)31(42)21(4)28(40)19(2)17-37(9,47-14)33(52-35-29(41)25(39(11)12)16-20(3)48-35)22(5)30(23(6)34(44)50-26)51-27-18-36(8,46-13)32(43)24(7)49-27;7-3(8)1-6(13,5(11)12)2-4(9)10/h19-27,29-33,35,41-43,45H,15-18H2,1-14H3;13H,1-2H2,(H,7,8)(H,9,10)(H,11,12)/t19-,20-,21+,22+,23-,24+,25+,26-,27+,29-,30+,31-,32+,33-,35+,36-,37-,38-;/m1./s1
    2.1.3 InChI Key
    MDRWXDRMSKEMRE-AZFLODHXSA-N
    2.1.4 Canonical SMILES
    CCC1C(C(C(C(=O)C(CC(C(C(C(C(C(=O)O1)C)OC2CC(C(C(O2)C)O)(C)OC)C)OC3C(C(CC(O3)C)N(C)C)O)(C)OC)C)C)O)(C)O.C(C(=O)O)C(CC(=O)O)(C(=O)O)O
    2.1.5 Isomeric SMILES
    CC[C@@H]1[C@@]([C@@H]([C@H](C(=O)[C@@H](C[C@@]([C@@H]([C@H]([C@@H]([C@H](C(=O)O1)C)O[C@H]2C[C@@]([C@H]([C@@H](O2)C)O)(C)OC)C)O[C@H]3[C@@H]([C@H](C[C@H](O3)C)N(C)C)O)(C)OC)C)C)O)(C)O.C(C(=O)O)C(CC(=O)O)(C(=O)O)O
    2.2 Other Identifiers
    2.2.1 UNII
    16K08R7NG0
    2.3 Synonyms
    2.3.1 Depositor-Supplied Synonyms

    1. Clarithromycin Citrate (1:1)

    2. 16k08r7ng0

    3. Erythromycin, 6-o-methyl-, 2-hydroxy-1,2,3-propanetricarboxylate (salt) (1:1)

    4. 848130-51-8

    5. Unii-16k08r7ng0

    6. Schembl6275870

    7. Clarithromycin Citrate [who-dd]

    8. Q27251822

    2.4 Create Date
    2013-07-08
    3 Chemical and Physical Properties
    Molecular Weight 940.1 g/mol
    Molecular Formula C44H77NO20
    Hydrogen Bond Donor Count8
    Hydrogen Bond Acceptor Count21
    Rotatable Bond Count13
    Exact Mass939.50389385 g/mol
    Monoisotopic Mass939.50389385 g/mol
    Topological Polar Surface Area315 Ų
    Heavy Atom Count65
    Formal Charge0
    Complexity1420
    Isotope Atom Count0
    Defined Atom Stereocenter Count18
    Undefined Atom Stereocenter Count0
    Defined Bond Stereocenter Count0
    Undefined Bond Stereocenter Count0
    Covalently Bonded Unit Count2
    Post Enquiry
    POST ENQUIRY